Evidence map›Paper›PMID 24238783›Full record

ArticleBiological psychiatry2014

Brain potentials measured during a Go/NoGo task predict completion of substance abuse treatment.

Vaughn R Steele, Brandi C Fink, J Michael Maurer, Mohammad R Arbabshirani, Charles H Wilber, Adam J Jaffe, Anna Sidz, Godfrey D Pearlson, Vince D Calhoun, Vincent P Clark and 1 more

Abstract read
In one paragraph

Article in Biological psychiatry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Neural signature of error processing in major depression.European archives of psychiatry and clinical neuroscience · 2021
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Vaughn R SteeleMind Research Network and Lovelace Biomedical and Environmental Research Institute, University of New Mexico, Albuquerque, New Mexico; Department of Psychology, University of New Mexico, Albuquerque, New Mexico. Electronic address: vrsteele@mrn.org.
Brandi C FinkDepartment of Psychology, University of New Mexico, Albuquerque, New Mexico.
J Michael MaurerMind Research Network and Lovelace Biomedical and Environmental Research Institute, University of New Mexico, Albuquerque, New Mexico.
Mohammad R ArbabshiraniMind Research Network and Lovelace Biomedical and Environmental Research Institute, University of New Mexico, Albuquerque, New Mexico; Department of Psychology, University of New Mexico, Albuquerque, New Mexico.
Charles H WilberHartford Hospital Institute of Living, Hartford.
Adam J JaffeHartford Hospital Institute of Living, Hartford.
Anna SidzMind Research Network and Lovelace Biomedical and Environmental Research Institute, University of New Mexico, Albuquerque, New Mexico.
Godfrey D PearlsonYale University School of Medicine, New Haven; Olin Neuropsychiatry Research Center, Institute of Living; Hartford, Connecticut.
Vince D CalhounMind Research Network and Lovelace Biomedical and Environmental Research Institute, University of New Mexico, Albuquerque, New Mexico; Department of Psychology, University of New Mexico, Albuquerque, New Mexico.
Vincent P ClarkMind Research Network and Lovelace Biomedical and Environmental Research Institute, University of New Mexico, Albuquerque, New Mexico; Department of Psychology, University of New Mexico, Albuquerque, New Mexico.
Kent A KiehlMind Research Network and Lovelace Biomedical and Environmental Research Institute, University of New Mexico, Albuquerque, New Mexico; Department of Psychology, University of New Mexico, Albuquerque, New Mexico.
University of New Mexico · USHartford Hospital · USMind Research Network · USHartford Financial Services (United States)

Funding

University of New Mexico Center for Metals in Biology and Medicine - equipment supplementP20GM130422 · NIGMS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Changjian (Jim) Feng · 2020 to 2026
$20.4M
Alcohol Research Training: Methods & MechanismsT32AA018108 · NIAAA · UNIVERSITY OF NEW MEXICO · PI Katie A Witkiewitz · 2010 to 2026
$5.6M
University of New Mexico Clinical and Translational Science CenterKL2TR001448 · NCATS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI CANNON, JUDY LIN · 2015 to 2024
$3.5M
Neurocognitive Changes Associated with Behavioral Treatment in Cocaine AbusersR01DA020870 · NIDA · THE MIND RESEARCH NETWORK · PI KIEHL, KENT A · 2005 to 2009
$3.0M
Action Monitoring, Action Observation and Dopamine Genes as Predictors of SubstanR01DA026964 · NIDA · THE MIND RESEARCH NETWORK · PI KIEHL, KENT A · 2010 to 2014
$2.9M
NCATS NIH HHS KL2 TR001448NIAAA NIH HHS 1 T32 AA018108-01A1NIAAA NIH HHS L30 AA021608NIAAA NIH HHS T32 AA018108NIDA NIH HHS 1 R01 DA020870-01NIDA NIH HHS R01 DA020870NIDA NIH HHS R01 DA026964NIGMS NIH HHS P20 GM130422
6 · The paper itself

Abstract

backgroundU.S. nationwide estimates indicate that 50% to 80% of prisoners have a history of substance abuse or dependence. Tailoring substance abuse treatment to specific needs of incarcerated individuals could improve effectiveness of treating substance dependence and preventing drug abuse relapse. We tested whether pretreatment neural measures of a response inhibition (Go/NoGo) task would predict which individuals would or would not complete a 12-week cognitive behavioral substance abuse treatment program.

methodsAdult incarcerated participants (n = 89; women n = 55) who volunteered for substance abuse treatment performed a Go/NoGo task while event-related potentials (ERPs) were recorded. Stimulus- and response-locked ERPs were compared between participants who completed (n = 68; women = 45) and discontinued (n = 21; women = 10) treatment.

resultsAs predicted, stimulus-locked P2, response-locked error-related negativity (ERN/Ne), and response-locked error positivity (Pe), measured with windowed time-domain and principal component analysis, differed between groups. Using logistic regression and support-vector machine (i.e., pattern classifiers) models, P2 and Pe predicted treatment completion above and beyond other measures (i.e., N2, P300, ERN/Ne, age, sex, IQ, impulsivity, depression, anxiety, motivation for change, and years of drug abuse).

conclusionsParticipants who discontinued treatment exhibited deficiencies in sensory gating, as indexed by smaller P2; error-monitoring, as indexed by smaller ERN/Ne; and adjusting response strategy posterror, as indexed by larger Pe. The combination of P2 and Pe reliably predicted 83.33% of individuals who discontinued treatment. These results may help in the development of individualized therapies, which could lead to more favorable, long-term outcomes.

Indexed as

BrainEvoked PotentialsFemaleHumansMalePatient CompliancePrisonersPsychomotor PerformanceReaction TimeSubstance-Related DisordersDrug treatmentevent-related potentialspattern classifierprincipal component analysisresponse errorsresponse inhibitionsupport vector machine

Identifiers

PMID24238783
PMCPMC3984370
OpenAlexW2088658039

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.